Examples of 'tissue plasminogen activator' in a sentence
Meaning of "tissue plasminogen activator"
tissue plasminogen activator - Tissue plasminogen activator (TPA) is a protein involved in the breakdown of blood clots. It is used in medicine as a thrombolytic agent to dissolve blood clots in conditions such as heart attacks or strokes
How to use "tissue plasminogen activator" in a sentence
Basic
Advanced
tissue plasminogen activator
Stabilized human tissue plasminogen activator compositions.
Fibrin is a cofactor for plasminogen activation by tissue plasminogen activator.
Take a tissue plasminogen activator to dissolve the clot.
The commercial production of recombinant human tissue plasminogen activator is an example.
Tissue plasminogen activator human.
Recombinant tissue plasminogen activator.
Tissue plasminogen activator is released by endothelial cells and activated platelets.
This medication is called tissue plasminogen activator or tPA treatment.
Tissue plasminogen activator glycosylation variants with improved therapeutic properties.
This drug blocks the production of plasminogen and tissue plasminogen activator.
It also inhibits tissue plasminogen activator and urokinase.
Physical exercise enhances endogenous fibrinolytic activity manifested as a reduction in tissue plasminogen activator.
It is a tissue plasminogen activator.
The signal sequence was a modified prepro sequence from human tissue plasminogen activator.
Tissue plasminogen activator analogs having modified growth factor domains.
See also
The active enzyme also appears to increase fibrinolysis by activating tissue plasminogen activator inhibitor.
Intravenous thrombolysis with tissue plasminogen activator is the only treatment for stroke with proved benefit.
A process according to any of the preceding claims wherein said protein is a tissue plasminogen activator.
Purification of human tissue plasminogen activator with Erythrina trypsin inhibitor.
Milk from the transgenic dairy goat contained the modified tissue plasminogen activator.
In addition, tissue plasminogen activator is now being developed.
Treatment of central retinal vein occlusion by injection of tissue plasminogen activator into a retinal vein.
Further, the recombinant tissue plasminogen activator can be alteplase, reteplase or tenecteplase.
This part of the present polypeptide is derived from a native tissue plasminogen activator polypeptide.
Tissue plasminogen activator binds to plasminogen within the clot, converting it into plasmin.
The thrombolytic agent used in the present invention is preferably tissue plasminogen activator or urokinase.
More specifically, it relates to tissue plasminogen activator analogs having a modified kringle domain.
The method of claim 4, wherein the thrombolytic agent is a tissue plasminogen activator.
Surgical trauma releases the tissue plasminogen activator t-PA and the fibrinolytic system is activated.
Further thrombotic events could be treated with Tissue plasminogen activator tPA.
Tissue plasminogen activator ( tPA ) is a serine protease induces opening of the blood brain barrier.
The authors employed a purification scheme that affords tissue plasminogen activator at relatively high purity levels.
Tissue plasminogen activator ( tPA ) was also added at time zero to induce subsequent clot dissolution.
Annexin II organizes the assembly of tissue plasminogen activator and plasminogen on its surface.
The process according to claim 5 in which the plasminogen activator is tissue plasminogen activator.
More specifically, it relates to tissue plasminogen activator analogs having a modified growth factor domain.
Preferably, the thrombolytic agent is a human tissue plasminogen activator.
Tissue plasminogen activator ( tPA ) is a serine protease involved with the dissolution of blood clots.
Synthesis and purification of active human tissue plasminogen activator from Escherichia coli.
Tissue plasminogen activator ( tpa ) regulates coagulation and catalyzes processes that prevent brain atrophy.
In particular embodiments, the fibrinolytic agent is tissue plasminogen activator or streptokinase.
Tissue plasminogen activator inhibitor PAI-1 is an important inhibitor of the fibrinolytic system.
Eton et al . implanted myointimal cells transduced with tissue plasminogen activator genes.
K2S domain of human tissue plasminogen activator or a functional variant, thereof is produced.
In a more preferred embodiment the antithrombotic is recombinant tissue plasminogen activator ( tPA ).
Tissue plasminogen activator is a protein encoded by the PLAT gene, which is located on chromosome 8.
Profibrinolytic agents include urokinase, streptokinase, tissue plasminogen activator or derivatives thereof.
Injection of tissue plasminogen activator ( a fibrinolytic drug ) in the CSF improved glymphatic functioning.
More preferably, the thrombolytic agent is recombinant human tissue plasminogen activator.
Tissue plasminogen activator ( tPA ) is a complex mammalian protein.
You'll also be interested in:
Examples of using Plasminogen
Show more
So to replace the plasminogen in the first place
Plasmin is a serine protease derived from plasminogen
Tissue plasminogen activators are found in many tissues
Examples of using Tissue
Show more
New tissue paper with ftoral fragrance
Clonal selection versus tissue culture production
Tissue death due to clots in the bloodstream
Examples of using Activator
Show more
Add catalyst activator and mix throroughly
Activator of the defence mechanisms against cancer
Only uses as a plant activator may be authorised
